SciVision Biotech

SciVision Biotech EBITDA per Share

The EBITDA per Share of SciVision Biotech (1786.TW) as of Oct 17, 2026 is 2.59 TWD. In the previous year, EBITDA per Share was 3.18 TWD — a change of -18.42% (lower).

EBITDA per Share

2.59TWD

YoY

-18.42%

Last updated:

EBITDA per Share of SciVision Biotech is 2025 2.59 TWD. EBITDA per Share of SciVision Biotech was 2024 3.18 TWD. It decreases by -18.42% lower compared to the previous year.

The SciVision Biotech EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
1.38 TWD
Jan 1, 2019
2.12 TWD
Jan 1, 2020
2.46 TWD
Jan 1, 2021
1.75 TWD
Jan 1, 2022
2.67 TWD
Jan 1, 2023
2.37 TWD
Jan 1, 2024
3.18 TWD
Jan 1, 2025
2.59 TWD
The SciVision Biotech EBITDA per Share history
YEAREBITDA per ShareYoY
2.59TWD-18.42%
3.18TWD+33.97%
2.37TWD-11.08%
2.67TWD+52.52%
1.75TWD-28.76%
2.46TWD+16.17%
2.12TWD+53.70%
1.38TWD+138.57%
0.58TWD-232.98%
-0.43TWD-156.22%
0.77TWD-284.21%
-0.42TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SciVision Biotech Stock analysis

What does SciVision Biotech do? SciVision Biotech Inc, based in Kaohsiung, Taiwan, specializes in the research, development, and production of hyaluronic acid medical products. The company offers subcutaneous fillers for plastic surgery, joint cavity injections for orthopedics, and hyaluronic acid raw materials. It also provides DNA identification, detection, sequencing, and related applications, alongside care products and food manufacturing. SciVision Biotech operates globally across the Americas, Europe, Asia, the Middle East, and Africa. SciVision Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SciVision Biotech stock

EBITDA per Share of SciVision Biotech is 2.59 TWD in 2025.

EBITDA per Share of SciVision Biotech changed from 3.18 TWD to 2.59 TWD, representing a -18.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share SciVision Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — SciVision Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — SciVision Biotech